Scope Fluidics S.A. (GPW: SCP) Stock Analysis & Fundamentals | ScreenerHero

Create free account

SCPScope Fluidics S.A.

GPW · PL · Healthcare · Diagnostics & Research · scopefluidics.com

—Mkt Cap: —P/E: —

Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. The company offers BacterOMIC, an antibiotic susceptibility …

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/B

Avg

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

$43.51BUSDP/E 42.0

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.12BUSDP/E 33.3

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.81BUSDP/E 20.6

Twist Bioscience Corporation

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

DiaSorin S.p.A.

$3.65BUSDP/E 25.7

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.48BUSDP/E 37.4

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

Castle Biosciences, Inc.

$615.20MUSDP/E 40.1

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap—

Enterprise Value—

Revenue (TTM)26.34K $

Gross Profit-921.36K $

Net Income (TTM)-11.74M $

Revenue/Share0.0081 USD

Last Price—

Fiscal Year End—

MR Quarter—

Employees157

CountryPL

SectorHealthcare

IndustryDiagnostics & Research

ISINPLSCPFL00018

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S3613.05

P/B2.52

EPS (TTM)-16.97

EPS (Forward)—

52W Range

—

52W High—

52W Low—

Profitability

Gross Margin-3638.00%

Oper. Margin-53814.82%

EBITDA Margin0.00%

Profit Margin-46364.00%

ROE-28.54%

ROA-23.66%

Growth

Revenue Growth17.40%

Earnings Growth—

Cash Flow & Leverage

Operating CF-11.68M $

CapEx (TTM)3.39M $

FCF Margin-38088.22%

FCF Yield—

Net Debt-34.43M $

Net Debt/EBITDA2.71

Balance Sheet

Debt/Equity0.01

Current Ratio11.81

Quick Ratio11.20

Book Value/Sh47.02 PLN

Cash/Share43.63 PLN

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 PLN

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div DateMar 24, 2023

Pay Date—

Analyst Consensus

Rating—

Target (Mean)198.20 PLN

Target Range198.20 PLN – 198.20 PLN

# Analysts1

Ownership

Shares Out.3.17M

Float1.89M

Insiders22.85%

Institutions16.72%

Technical

SMA 50124.96 PLN

SMA 200143.62 PLN

Beta0.00

S&P 52W Chg20.05%

Avg Vol (30d)—

Avg Vol (10d)669

Technical Indicators

RSI (14)40.4

MACD-1.2778

MACD Signal-1.0508

MACD Hist.-0.2270

BB Upper127.11 PLN

BB Middle122.07 PLN

BB Lower117.03 PLN

BB Width8.26%

ATR (14)3.710 PLN

Vol Ratio (20d)1.35x